- India’s largest drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal  CNBC
- Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal  WSJ
- Sun Pharma to acquire US-based Organon in $11.75 billion deal, among biggest overseas buys by Indian firms  The Times of India
- Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal  Bloomberg
- Sun Pharma shares jump over 5% after Organon acquisition; Macquarie sees debt-free status in 3-4 years  Moneycontrol.com
​India’s largest drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal  CNBCSun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal  WSJSun Pharma to acquire US-based Organon in $11.75 billion deal, among biggest overseas buys by Indian firms  The Times of IndiaSun Pharma to Acquire US-Listed Organon in $12 Billion Deal  BloombergSun Pharma shares jump over 5% after Organon acquisition; Macquarie sees debt-free status in 3-4 years  Moneycontrol.com by Soban News (international And National News)